The key COVID-19 findings in geriatrics, distilled into a clear, readable brief. The evidence is here whenever you want to go deeper.
INSIDE THIS MONITOR
31cited sources
7available findings
Study findings updated
AI-assisted evidence summary. For general information. These findings are not individual medical advice or a clinician endorsement.
THE SHORT VERSION
What’s worth knowing.
The key findings, what they mean, and the context that matters.
THE HEADLINE TAKEAWAY4.6-fold higher
Long-term care residents had 4.6-fold higher COVID-19 mortality
In reviewed U.S. evidence, COVID-19 mortality among long-term care facility residents was 4.6-fold higher than among community-dwelling individuals; residents accounted for approximately 1 in 6 COVID-19 hospitalizations.
Systematic review of U.S. evidence. All included studies covered Omicron-period data, while most also included earlier variants.
See the evidence
Mortality among LTCF residents compared with community-dwelling individuals in the reviewed U.S. evidence; all studies included Omicron-period data, but most also covered earlier variants.
4.6-fold higher
Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.
Proportion of COVID-19 hospitalizations occurring among LTCF residents in the reviewed U.S. evidence; all studies included Omicron-period data, but most also covered earlier variants.
Approximately 1 in 6
Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.
Long-term care residents had 4.6-fold higher COVID-19 mortality
4.6-fold higher
In reviewed U.S. evidence, COVID-19 mortality among long-term care facility residents was 4.6-fold higher than among community-dwelling individuals; residents accounted for approximately 1 in 6 COVID-19 hospitalizations.
Systematic review of U.S. evidence. All included studies covered Omicron-period data, while most also included earlier variants.
Study details & original results
Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.
Mortality among LTCF residents compared with community-dwelling individuals in the reviewed U.S. evidence; all studies included Omicron-period data, but most also covered earlier variants.
4.6-fold higher
Proportion of COVID-19 hospitalizations occurring among LTCF residents in the reviewed U.S. evidence; all studies included Omicron-period data, but most also covered earlier variants.
Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.
WHEN YOU WANT TO GO DEEPERSee all 7 findingsOriginal results, comparisons and study details.
5 of 5 source groupsFindings stay together with their study.
SOURCE 313 findings
Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.
Weekly COVID-19 infection and hospitalization incidence among U.S. nursing home residents; all reviewed studies included Omicron-period data, but most also included earlier variant periods.
Added
614-1338 infections and 38-71 hospitalizations per 1,000 residents per weekSource [31]
Proportion of COVID-19 hospitalizations occurring among LTCF residents in the reviewed U.S. evidence; all studies included Omicron-period data, but most also covered earlier variants.
Mortality among LTCF residents compared with community-dwelling individuals in the reviewed U.S. evidence; all studies included Omicron-period data, but most also covered earlier variants.
Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444-e451.
Browse the 31 original sourcesThe complete bibliography behind this monitor.
[1]
Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444-e451.
Maddocks M, Brighton LJ, Farquhar M, et al. Frailty transitions after COVID-19: A systematic review and meta-analysis. Age and Ageing. 2022;51(4):afac147.
Covino M, De Matteis G, Russo A, et al. Post-COVID Functional Decline in Older Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2022;70(6):1776-1789.
McMichael TM, Currie DW, Clark S, et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J Med. 2020;382:2005-2011.
Marzolini C, Kuritzkes DR, et al. Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions. Clin Pharmacol Ther. 2023;114(3):582-595.
Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.
This is an AI-assisted evidence summary, not a clinician endorsement. Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results.
Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed. Personal health and treatment decisions belong in a conversation with a qualified clinician.